PL
Protalix BioTherapeutics, Inc.
PLX · AMEX
$2.72 +1.87% (+$0.05)
1M +4.20%
Market Cap $219.2M
P/E Ratio 11.57x
Div. Yield -
ROE 31.61%
Bulios Fair Price
$1.55
43.0% downside
Trenutna cena
$2.72
Podcenjeno Poštena vrednost Precenjeno
Po podatkih Bulios Fair Price je delnica PLX trenutno precenjena glede na svojo tržno ceno. Kako deluje?
Bulios Fair Price je ocena poštene vrednosti delnice iz Buliosovega modela vrednotenja. Je vhod za vašo lastno analizo, ne naložbeno priporočilo. Kako deluje?
Piotroski F-Score Moderate
4/9Valuation
75 /100
Cheap EV/EBITDA 7.65x
P/S 2.72x
P/B 3.07x
Growth
37 /100
Stable Rev. growth 3.45%
FCF growth N/A
Book val. growth N/A
Profitability
89 /100
Strong Net margin 23.50%
Op. margin 28.89%
FCF margin 9.51%
Quality
94 /100
Excellent ROE 31.61%
ROA 17.17%
Asset turnover 0.73x
Debt
100 /100
Low Current ratio 2.94x
Int. coverage 19.77x
Net debt/EBITDA -0.69x
Stability
11 /100
Unstable Rev. volatility 28.65%
EPS volatility 231.92%
Profitable years 0
Bulios Scoring opisuje kakovost in preteklost podjetja, ne prihodnjega donosa. Visok rezultat ni nakupni signal. Izvedite več
Vprašajte StockBota o PLX
Online
Sector
Healthcare
Industry
Biotechnology
CEO
Dror Bashan
Employees
226
Headquarters
Hackensack
Prihajajoči dogodki
12 NOV.
Earnings
Upcoming earnings report